Daratumumab with Cetrelimab, an Anti–PD-1 Monoclonal Antibody, in Relapsed/Refractory Multiple Myeloma

Publication date: Available online 22 August 2020Source: Clinical Lymphoma Myeloma and LeukemiaAuthor(s): Yael C. Cohen, Albert Oriol, Ka Lung Wu, Noa Lavi, Philip Vlummens, Carolyn Jackson, Wendy Garvin, Robin Carson, Wendy Crist, Jiayu Fu, Huaibao Feng, Hong Xie, Jordan Schecter, Jesús San-Miguel, Sagar Lonial
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research